The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Share News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Reckitt Lifts 2020 Outlook As It Gets Stockpiling Boost

Thu, 30th Apr 2020 09:35

(Alliance News) - Reckitt Benckiser Group PLC on Thursday posted a double-digit first quarter revenue rise amid higher sales of hygiene and health products as a result of the virus pandemic, with the Dettol maker even nudging its 2020 outlook higher.

Reckitt said its "2020 performance is now expected to be better than original expectations" but conceded the "outlook for the balance of 2020 remains uncertain".

Total Reckitt sales climbed 12% to GBP3.54 billion in the quarter to March 31. On a like-for-like basis, sales were 13% higher.

The largest sales rise came from over-the-counter health products. These jumped by about a third to GBP618 million.

It helped the FTSE 100 company to a 13% sales hike in the Health unit to GBP2.19 billion.

In Hygiene, sales jumped 11% to GBP1.36 billion.

The "unfolding health crisis", led to shifts in consumer spending patterns, as many stocked up on goods now, in fear of shortages further down the line.

"The unfolding health crisis is an unprecedented situation for our global community and our thoughts are with those most affected, either on the front-line or dealing with the domestic and societal impacts of Covid-19," Reckitt said.

"RB is uniquely positioned to help build healthier communities with a portfolio that includes not only leading brands such as Dettol and Lysol, which break the chain of infection, but also Mucinex, Lemsip, Durex, Nurofen and Strepsils, as well as our Nutrition portfolio."

Last Friday, Reckitt warned that under "no circumstance" should disinfectants be injected or consumed, following comments made by Donald Trump. The US president suffered a backlash after suggesting it would be "interesting to check" whether a disinfectant injection could help combat coronavirus.

Although expecting a better 2020 than initially anticipated, Reckitt warned operating costs willl be higher, "particularly in our supply chain, as we keep our people safe, mitigate disruptions and serve the needs of our consumers".

Shares in the company were 4.3% higher at 6,680.00 pence each in London on Thursday morning.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Jul 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jul 2020 13:32

Monday broker round-up

(Sharecast News) - British American Tobacco: Jefferies downgrades to hold with a target price of 3,000.0p.

Read more
20 Jul 2020 11:23

Deutsche Bank raises target price on Reckitt Benckiser

(Sharecast News) - Analysts at Deutsche Bank upped their target price on consumer goods company Reckitt Benckiser from 7,400.0p to 8,400.0p on Monday, highlighting the group's "enduring fame".

Read more
20 Jul 2020 09:38

UK BROKER RATINGS SUMMARY: Barclays Downgrades Standard Life Aberdeen

UK BROKER RATINGS SUMMARY: Barclays Downgrades Standard Life Aberdeen

Read more
16 Jul 2020 22:34

Brazilian waste management firm finds cost-cutting users in pandemic

By Tatiana BautzerSAO PAULO, July 16 (Reuters) - A month-old Brazilian company's machines that use bacteria to break down organic waste has found users among domestic upscale supermarket Natural da Terra, units of Reckitt Benckiser and Siemens AG ...

Read more
10 Jul 2020 09:43

UK BROKER RATINGS SUMMARY: Investec Ups Barclays; HSBC Cuts RSA

UK BROKER RATINGS SUMMARY: Investec Ups Barclays; HSBC Cuts RSA

Read more
9 Jul 2020 13:51

Thursday broker round-up

(Sharecast News) - Hargreaves Lansdown: Berenberg reiterates hold with a target price of 1,830.0p.

Read more
9 Jul 2020 09:36

UK BROKER RATINGS SUMMARY: RBC Downgrades Compass To Underperform

UK BROKER RATINGS SUMMARY: RBC Downgrades Compass To Underperform

Read more
6 Jul 2020 09:15

UK BROKER RATINGS SUMMARY: Credit Suisse Downgrades BHP To Neutral

UK BROKER RATINGS SUMMARY: Credit Suisse Downgrades BHP To Neutral

Read more
30 Jun 2020 21:48

UPDATE 2-Former Indivior CEO pleads guilty in U.S. in opioid addiction treatment probe

(Adds comment from defense lawyer and Indivior)By Nate RaymondJune 30 (Reuters) - Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investig...

Read more
30 Jun 2020 21:48

UPDATE 1-Former Indivior CEO pleads guilty in U.S. in opioid addiction treatment probe

(Adds further details on case, background on investigation)By Nate RaymondJune 30 (Reuters) - Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Departm...

Read more
30 Jun 2020 14:20

Tuesday broker round-up

(Sharecast News) - Paragon: Canaccord upgrades to buy with a target price of 454.0p.

Read more
30 Jun 2020 09:31

UK BROKER RATINGS SUMMARY: Exane BNP Downgrades RELX To Underperform

UK BROKER RATINGS SUMMARY: Exane BNP Downgrades RELX To Underperform

Read more
29 Jun 2020 13:45

Monday broker round-up

(Sharecast News) - Balfour Beatty: Jefferies downgrades to hold with a target price of 260.0p.

Read more
29 Jun 2020 10:29

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.